Loading…

Increased IL‐15 production of muscle cells in polymyositis and dermatomyositis

In polymyositis (PM)/dermatomyositis (DM), various cytokines, especially macrophage‐derived cytokines such as IL‐1α, IL‐1β and tumor necrosis factor (TNF)‐α, are expressed in the inflammatory foci. We previously reported that IL‐15, a novel cytokine with a biological activity similar to that of IL‐2...

Full description

Saved in:
Bibliographic Details
Published in:International immunology 2002-08, Vol.14 (8), p.917-924
Main Authors: Sugiura, Tomoko, Harigai, Masayoshi, Kawaguchi, Yasushi, Takagi, Kae, Fukasawa, Chikako, Ohsako‐Higami, Satomi, Ohta, Shuji, Tanaka, Michi, Hara, Masako, Kamatani, Naoyuki
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c497t-1b1939dadb2900781c75faff72a43442dd58113045b13f265516f2719a10f5623
cites
container_end_page 924
container_issue 8
container_start_page 917
container_title International immunology
container_volume 14
creator Sugiura, Tomoko
Harigai, Masayoshi
Kawaguchi, Yasushi
Takagi, Kae
Fukasawa, Chikako
Ohsako‐Higami, Satomi
Ohta, Shuji
Tanaka, Michi
Hara, Masako
Kamatani, Naoyuki
description In polymyositis (PM)/dermatomyositis (DM), various cytokines, especially macrophage‐derived cytokines such as IL‐1α, IL‐1β and tumor necrosis factor (TNF)‐α, are expressed in the inflammatory foci. We previously reported that IL‐15, a novel cytokine with a biological activity similar to that of IL‐2, is expressed in muscle cells in PM/DM. In the present study, we set out to investigate the regulation of IL‐15 in cultured myoblasts. Myoblasts constitutively produced a low level of IL‐15 and the production was augmented by stimulation with IFN‐γ, IL‐1α, IL‐1β, TNF‐α or lipopolysaccharide (LPS) in a dose‐dependent manner. These stimuli also enhanced the expression of IL‐15 mRNA. About 30–40% of IL‐15 was detected intracellularly, while the rest was released into the culture supernatant. Immunohistochemical staining revealed that intracellular IL‐15 was localized in the perinuclear area of the cytoplasm in the myoblasts. Despite the considerable amounts of intracellular IL‐15, the myoblasts predominantly expressed authentic IL‐15 mRNA isoform. This isoform generates IL‐15 with long signal peptide preprotein, which is all to be secreted. The biological activity of IL‐15 secreted from the myoblasts was examined using an IL‐15‐dependent murine T cell line, CTLL‐2. Culture supernatants of the myoblasts induced a proliferative response of CTLL‐2 and this was specifically inhibited by anti‐IL‐15 antibody. These results suggest that inflammatory stimuli induce the production of IL‐15 in the muscle cells in PM/DM, and IL‐15 may contribute to the immunopathogenesis by augmenting recruitment and activation of the infiltrating T cells. Blocking of IL‐15 production might be of therapeutic value in PM/DM.
doi_str_mv 10.1093/intimm/dxf062
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71951601</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>325363301</sourcerecordid><originalsourceid>FETCH-LOGICAL-c497t-1b1939dadb2900781c75faff72a43442dd58113045b13f265516f2719a10f5623</originalsourceid><addsrcrecordid>eNqFkcFqGzEQhkVJaNy0x16LyCG3TTTSaqU9JqZ1DIbkkIDxRcgrCZTurlxpF-JbHyHP2Cepgp0YcslpYOabn3_mR-g7kAsgNbv0_eC77tI8OVLRT2gCZUUKyoQ4QhNSc1ZIEPIEfUnpkRDCaM0-oxOgUIqKygm6m_dNtDpZg-eLf3-fgeNNDGZsBh96HBzuxtS0Fje2bRP2Pd6EdtttQ_KDT1j3BhsbOz2E195XdOx0m-y3fT1FD79-3k9visXtbD69WhRNWYuhgDXUrDbarGlNiJDQCO60c4LqkpUlNYZLAEZKvgbmaMU5VI4KqDUQxyvKTtH5Tjfb_TPaNKjOpxeXurdhTCqjeYXAhyBILvO_ZAbP3oGPYYx9PkJlLUKZLEWGih3UxJBStE5tou903Cog6iUQtQtE7QLJ_I-96LjurDnQ-wQOgj4N9ultruNvVQkmuLpZrtRSXK9Ws-lUzdh_maqXbQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195023847</pqid></control><display><type>article</type><title>Increased IL‐15 production of muscle cells in polymyositis and dermatomyositis</title><source>Oxford Journals Online</source><creator>Sugiura, Tomoko ; Harigai, Masayoshi ; Kawaguchi, Yasushi ; Takagi, Kae ; Fukasawa, Chikako ; Ohsako‐Higami, Satomi ; Ohta, Shuji ; Tanaka, Michi ; Hara, Masako ; Kamatani, Naoyuki</creator><creatorcontrib>Sugiura, Tomoko ; Harigai, Masayoshi ; Kawaguchi, Yasushi ; Takagi, Kae ; Fukasawa, Chikako ; Ohsako‐Higami, Satomi ; Ohta, Shuji ; Tanaka, Michi ; Hara, Masako ; Kamatani, Naoyuki</creatorcontrib><description>In polymyositis (PM)/dermatomyositis (DM), various cytokines, especially macrophage‐derived cytokines such as IL‐1α, IL‐1β and tumor necrosis factor (TNF)‐α, are expressed in the inflammatory foci. We previously reported that IL‐15, a novel cytokine with a biological activity similar to that of IL‐2, is expressed in muscle cells in PM/DM. In the present study, we set out to investigate the regulation of IL‐15 in cultured myoblasts. Myoblasts constitutively produced a low level of IL‐15 and the production was augmented by stimulation with IFN‐γ, IL‐1α, IL‐1β, TNF‐α or lipopolysaccharide (LPS) in a dose‐dependent manner. These stimuli also enhanced the expression of IL‐15 mRNA. About 30–40% of IL‐15 was detected intracellularly, while the rest was released into the culture supernatant. Immunohistochemical staining revealed that intracellular IL‐15 was localized in the perinuclear area of the cytoplasm in the myoblasts. Despite the considerable amounts of intracellular IL‐15, the myoblasts predominantly expressed authentic IL‐15 mRNA isoform. This isoform generates IL‐15 with long signal peptide preprotein, which is all to be secreted. The biological activity of IL‐15 secreted from the myoblasts was examined using an IL‐15‐dependent murine T cell line, CTLL‐2. Culture supernatants of the myoblasts induced a proliferative response of CTLL‐2 and this was specifically inhibited by anti‐IL‐15 antibody. These results suggest that inflammatory stimuli induce the production of IL‐15 in the muscle cells in PM/DM, and IL‐15 may contribute to the immunopathogenesis by augmenting recruitment and activation of the infiltrating T cells. Blocking of IL‐15 production might be of therapeutic value in PM/DM.</description><identifier>ISSN: 0953-8178</identifier><identifier>ISSN: 1460-2377</identifier><identifier>EISSN: 1460-2377</identifier><identifier>DOI: 10.1093/intimm/dxf062</identifier><identifier>PMID: 12147628</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Animals ; Case-Control Studies ; Cell Line ; Cells, Cultured ; Cytokines - pharmacology ; dermatomyositis ; Dermatomyositis - genetics ; Dermatomyositis - immunology ; Gene Expression ; Humans ; IL‐15 ; Immunohistochemistry ; Inflammation Mediators - metabolism ; Interleukin-15 - biosynthesis ; Interleukin-15 - genetics ; Lipopolysaccharides - pharmacology ; Lymphocyte Activation ; Mice ; muscle cells ; Myoblasts, Skeletal - drug effects ; Myoblasts, Skeletal - immunology ; polymyositis ; Polymyositis - genetics ; Polymyositis - immunology ; RNA, Messenger - genetics ; RNA, Messenger - metabolism ; T-Lymphocytes - immunology</subject><ispartof>International immunology, 2002-08, Vol.14 (8), p.917-924</ispartof><rights>Copyright Oxford University Press(England) Aug 2002</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c497t-1b1939dadb2900781c75faff72a43442dd58113045b13f265516f2719a10f5623</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12147628$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sugiura, Tomoko</creatorcontrib><creatorcontrib>Harigai, Masayoshi</creatorcontrib><creatorcontrib>Kawaguchi, Yasushi</creatorcontrib><creatorcontrib>Takagi, Kae</creatorcontrib><creatorcontrib>Fukasawa, Chikako</creatorcontrib><creatorcontrib>Ohsako‐Higami, Satomi</creatorcontrib><creatorcontrib>Ohta, Shuji</creatorcontrib><creatorcontrib>Tanaka, Michi</creatorcontrib><creatorcontrib>Hara, Masako</creatorcontrib><creatorcontrib>Kamatani, Naoyuki</creatorcontrib><title>Increased IL‐15 production of muscle cells in polymyositis and dermatomyositis</title><title>International immunology</title><addtitle>Int. Immunol</addtitle><description>In polymyositis (PM)/dermatomyositis (DM), various cytokines, especially macrophage‐derived cytokines such as IL‐1α, IL‐1β and tumor necrosis factor (TNF)‐α, are expressed in the inflammatory foci. We previously reported that IL‐15, a novel cytokine with a biological activity similar to that of IL‐2, is expressed in muscle cells in PM/DM. In the present study, we set out to investigate the regulation of IL‐15 in cultured myoblasts. Myoblasts constitutively produced a low level of IL‐15 and the production was augmented by stimulation with IFN‐γ, IL‐1α, IL‐1β, TNF‐α or lipopolysaccharide (LPS) in a dose‐dependent manner. These stimuli also enhanced the expression of IL‐15 mRNA. About 30–40% of IL‐15 was detected intracellularly, while the rest was released into the culture supernatant. Immunohistochemical staining revealed that intracellular IL‐15 was localized in the perinuclear area of the cytoplasm in the myoblasts. Despite the considerable amounts of intracellular IL‐15, the myoblasts predominantly expressed authentic IL‐15 mRNA isoform. This isoform generates IL‐15 with long signal peptide preprotein, which is all to be secreted. The biological activity of IL‐15 secreted from the myoblasts was examined using an IL‐15‐dependent murine T cell line, CTLL‐2. Culture supernatants of the myoblasts induced a proliferative response of CTLL‐2 and this was specifically inhibited by anti‐IL‐15 antibody. These results suggest that inflammatory stimuli induce the production of IL‐15 in the muscle cells in PM/DM, and IL‐15 may contribute to the immunopathogenesis by augmenting recruitment and activation of the infiltrating T cells. Blocking of IL‐15 production might be of therapeutic value in PM/DM.</description><subject>Animals</subject><subject>Case-Control Studies</subject><subject>Cell Line</subject><subject>Cells, Cultured</subject><subject>Cytokines - pharmacology</subject><subject>dermatomyositis</subject><subject>Dermatomyositis - genetics</subject><subject>Dermatomyositis - immunology</subject><subject>Gene Expression</subject><subject>Humans</subject><subject>IL‐15</subject><subject>Immunohistochemistry</subject><subject>Inflammation Mediators - metabolism</subject><subject>Interleukin-15 - biosynthesis</subject><subject>Interleukin-15 - genetics</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Lymphocyte Activation</subject><subject>Mice</subject><subject>muscle cells</subject><subject>Myoblasts, Skeletal - drug effects</subject><subject>Myoblasts, Skeletal - immunology</subject><subject>polymyositis</subject><subject>Polymyositis - genetics</subject><subject>Polymyositis - immunology</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - metabolism</subject><subject>T-Lymphocytes - immunology</subject><issn>0953-8178</issn><issn>1460-2377</issn><issn>1460-2377</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNqFkcFqGzEQhkVJaNy0x16LyCG3TTTSaqU9JqZ1DIbkkIDxRcgrCZTurlxpF-JbHyHP2Cepgp0YcslpYOabn3_mR-g7kAsgNbv0_eC77tI8OVLRT2gCZUUKyoQ4QhNSc1ZIEPIEfUnpkRDCaM0-oxOgUIqKygm6m_dNtDpZg-eLf3-fgeNNDGZsBh96HBzuxtS0Fje2bRP2Pd6EdtttQ_KDT1j3BhsbOz2E195XdOx0m-y3fT1FD79-3k9visXtbD69WhRNWYuhgDXUrDbarGlNiJDQCO60c4LqkpUlNYZLAEZKvgbmaMU5VI4KqDUQxyvKTtH5Tjfb_TPaNKjOpxeXurdhTCqjeYXAhyBILvO_ZAbP3oGPYYx9PkJlLUKZLEWGih3UxJBStE5tou903Cog6iUQtQtE7QLJ_I-96LjurDnQ-wQOgj4N9ultruNvVQkmuLpZrtRSXK9Ws-lUzdh_maqXbQ</recordid><startdate>20020801</startdate><enddate>20020801</enddate><creator>Sugiura, Tomoko</creator><creator>Harigai, Masayoshi</creator><creator>Kawaguchi, Yasushi</creator><creator>Takagi, Kae</creator><creator>Fukasawa, Chikako</creator><creator>Ohsako‐Higami, Satomi</creator><creator>Ohta, Shuji</creator><creator>Tanaka, Michi</creator><creator>Hara, Masako</creator><creator>Kamatani, Naoyuki</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20020801</creationdate><title>Increased IL‐15 production of muscle cells in polymyositis and dermatomyositis</title><author>Sugiura, Tomoko ; Harigai, Masayoshi ; Kawaguchi, Yasushi ; Takagi, Kae ; Fukasawa, Chikako ; Ohsako‐Higami, Satomi ; Ohta, Shuji ; Tanaka, Michi ; Hara, Masako ; Kamatani, Naoyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c497t-1b1939dadb2900781c75faff72a43442dd58113045b13f265516f2719a10f5623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Case-Control Studies</topic><topic>Cell Line</topic><topic>Cells, Cultured</topic><topic>Cytokines - pharmacology</topic><topic>dermatomyositis</topic><topic>Dermatomyositis - genetics</topic><topic>Dermatomyositis - immunology</topic><topic>Gene Expression</topic><topic>Humans</topic><topic>IL‐15</topic><topic>Immunohistochemistry</topic><topic>Inflammation Mediators - metabolism</topic><topic>Interleukin-15 - biosynthesis</topic><topic>Interleukin-15 - genetics</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Lymphocyte Activation</topic><topic>Mice</topic><topic>muscle cells</topic><topic>Myoblasts, Skeletal - drug effects</topic><topic>Myoblasts, Skeletal - immunology</topic><topic>polymyositis</topic><topic>Polymyositis - genetics</topic><topic>Polymyositis - immunology</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - metabolism</topic><topic>T-Lymphocytes - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sugiura, Tomoko</creatorcontrib><creatorcontrib>Harigai, Masayoshi</creatorcontrib><creatorcontrib>Kawaguchi, Yasushi</creatorcontrib><creatorcontrib>Takagi, Kae</creatorcontrib><creatorcontrib>Fukasawa, Chikako</creatorcontrib><creatorcontrib>Ohsako‐Higami, Satomi</creatorcontrib><creatorcontrib>Ohta, Shuji</creatorcontrib><creatorcontrib>Tanaka, Michi</creatorcontrib><creatorcontrib>Hara, Masako</creatorcontrib><creatorcontrib>Kamatani, Naoyuki</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sugiura, Tomoko</au><au>Harigai, Masayoshi</au><au>Kawaguchi, Yasushi</au><au>Takagi, Kae</au><au>Fukasawa, Chikako</au><au>Ohsako‐Higami, Satomi</au><au>Ohta, Shuji</au><au>Tanaka, Michi</au><au>Hara, Masako</au><au>Kamatani, Naoyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased IL‐15 production of muscle cells in polymyositis and dermatomyositis</atitle><jtitle>International immunology</jtitle><addtitle>Int. Immunol</addtitle><date>2002-08-01</date><risdate>2002</risdate><volume>14</volume><issue>8</issue><spage>917</spage><epage>924</epage><pages>917-924</pages><issn>0953-8178</issn><issn>1460-2377</issn><eissn>1460-2377</eissn><abstract>In polymyositis (PM)/dermatomyositis (DM), various cytokines, especially macrophage‐derived cytokines such as IL‐1α, IL‐1β and tumor necrosis factor (TNF)‐α, are expressed in the inflammatory foci. We previously reported that IL‐15, a novel cytokine with a biological activity similar to that of IL‐2, is expressed in muscle cells in PM/DM. In the present study, we set out to investigate the regulation of IL‐15 in cultured myoblasts. Myoblasts constitutively produced a low level of IL‐15 and the production was augmented by stimulation with IFN‐γ, IL‐1α, IL‐1β, TNF‐α or lipopolysaccharide (LPS) in a dose‐dependent manner. These stimuli also enhanced the expression of IL‐15 mRNA. About 30–40% of IL‐15 was detected intracellularly, while the rest was released into the culture supernatant. Immunohistochemical staining revealed that intracellular IL‐15 was localized in the perinuclear area of the cytoplasm in the myoblasts. Despite the considerable amounts of intracellular IL‐15, the myoblasts predominantly expressed authentic IL‐15 mRNA isoform. This isoform generates IL‐15 with long signal peptide preprotein, which is all to be secreted. The biological activity of IL‐15 secreted from the myoblasts was examined using an IL‐15‐dependent murine T cell line, CTLL‐2. Culture supernatants of the myoblasts induced a proliferative response of CTLL‐2 and this was specifically inhibited by anti‐IL‐15 antibody. These results suggest that inflammatory stimuli induce the production of IL‐15 in the muscle cells in PM/DM, and IL‐15 may contribute to the immunopathogenesis by augmenting recruitment and activation of the infiltrating T cells. Blocking of IL‐15 production might be of therapeutic value in PM/DM.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>12147628</pmid><doi>10.1093/intimm/dxf062</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0953-8178
ispartof International immunology, 2002-08, Vol.14 (8), p.917-924
issn 0953-8178
1460-2377
1460-2377
language eng
recordid cdi_proquest_miscellaneous_71951601
source Oxford Journals Online
subjects Animals
Case-Control Studies
Cell Line
Cells, Cultured
Cytokines - pharmacology
dermatomyositis
Dermatomyositis - genetics
Dermatomyositis - immunology
Gene Expression
Humans
IL‐15
Immunohistochemistry
Inflammation Mediators - metabolism
Interleukin-15 - biosynthesis
Interleukin-15 - genetics
Lipopolysaccharides - pharmacology
Lymphocyte Activation
Mice
muscle cells
Myoblasts, Skeletal - drug effects
Myoblasts, Skeletal - immunology
polymyositis
Polymyositis - genetics
Polymyositis - immunology
RNA, Messenger - genetics
RNA, Messenger - metabolism
T-Lymphocytes - immunology
title Increased IL‐15 production of muscle cells in polymyositis and dermatomyositis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T02%3A38%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20IL%E2%80%9015%20production%20of%20muscle%20cells%20in%20polymyositis%20and%20dermatomyositis&rft.jtitle=International%20immunology&rft.au=Sugiura,%20Tomoko&rft.date=2002-08-01&rft.volume=14&rft.issue=8&rft.spage=917&rft.epage=924&rft.pages=917-924&rft.issn=0953-8178&rft.eissn=1460-2377&rft_id=info:doi/10.1093/intimm/dxf062&rft_dat=%3Cproquest_cross%3E325363301%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c497t-1b1939dadb2900781c75faff72a43442dd58113045b13f265516f2719a10f5623%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=195023847&rft_id=info:pmid/12147628&rfr_iscdi=true